- PHYSSprott Physical Gold Trust$4.7BReported
PHYSQ4 2023
Sprott Physical Gold Trust
View full reportEPS
Estimated
$0.00
Actual
$1.68
Revenue
Estimated
$0.00
Actual
$22.2M
- TMCTmc$2.7BReported
TMCQ4 2023
Tmc
View full reportEPS
Estimated
-$0.16
Actual
-$0.1131.3%
Revenue
Estimated
$0.00
Actual
$0.00
- PSLVSprott Physical Silver Trust$2.3BReported
PSLVQ4 2023
Sprott Physical Silver Trust
View full reportEPS
Estimated
$0.00
Actual
$0.56
Revenue
Estimated
$0.00
Actual
-$2.9M
- STOKStoke Therapeutics$2.0BReported
STOKQ4 2023
Stoke Therapeutics
View full reportEPS
Estimated
-$0.64
Actual
-$0.605.7%
Revenue
Estimated
$3.3M
Actual
$2.8M15.2%
- JBIOAerovate$1.0BReported
JBIOQ4 2023
Aerovate
View full reportEPS
Estimated
-$0.68
Actual
-$0.748.8%
Revenue
Estimated
$0.00
Actual
$136.0K
- HEPSD-Market$1.0BReported
HEPSQ4 2023
D-Market
View full reportEPS
Estimated
—
Actual
-$0.07
Revenue
Estimated
$513.6M
Actual
$414.0M19.4%
- STROSutro$491MReported
STROQ4 2023
Sutro
View full reportEPS
Estimated
-$0.80
Actual
$0.52165.0%
Revenue
Estimated
$11.6M
Actual
$113.7M882.6%
- BKKTBakkt$491MReported
BKKTQ4 2023
Bakkt
View full reportEPS
Estimated
-$2.82
Actual
-$7.25157.2%
Revenue
Estimated
$16.0M
Actual
$214.5M1240.3%
- SGMTSagimet Biosciences$449MReported
SGMTQ4 2023
Sagimet Biosciences
View full reportEPS
Estimated
-$0.58
Actual
-$0.3441.4%
Revenue
Estimated
—
Actual
$0.00
- MPTIM-Tron Industries$379MReported
MPTIQ4 2023
M-Tron Industries
View full reportEPS
Estimated
$0.47
Actual
$0.0393.6%
Revenue
Estimated
$11.4M
Actual
$10.8M5.7%
- SMTISanara MedTech$218MReported
SMTIQ4 2023
Sanara MedTech
View full reportEPS
Estimated
-$0.13
Actual
-$0.0377.1%
Revenue
Estimated
$16.2M
Actual
$17.7M9.4%
- EQEquillium$180MReported
EQQ4 2023
Equillium
View full reportEPS
Estimated
-$0.17
Actual
-$0.0757.8%
Revenue
Estimated
$7.8M
Actual
$9.2M17.5%
- REKRRekor Systems$106MReported
REKRQ4 2023
Rekor Systems
View full reportEPS
Estimated
-$0.11
Actual
-$0.1649.2%
Revenue
Estimated
$10.5M
Actual
$11.1M5.3%
- SNXTD Synnex$19.8BReported
SNXQ1 2024
TD Synnex
View full reportEPS
Estimated
$2.96
Actual
$1.9334.7%
Revenue
Estimated
$14.6B
Actual
$14.0B4.3%
- MKCMcCormick$12.6BReported
MKCQ1 2024
McCormick
View full reportEPS
Estimated
$0.58
Actual
$0.626.2%
Revenue
Estimated
$1.5B
Actual
$1.6B3.5%
- GMEGameStop$9.7BReported
GMEQ4 2023
GameStop
View full reportEPS
Estimated
-$0.13
Actual
$0.22265.1%
Revenue
Estimated
$2.2B
Actual
$1.8B19.3%
- GDSGDS$7.1BReported
GDSQ4 2023
GDS
View full reportEPS
Estimated
-$0.40
Actual
-$0.1367.5%
Revenue
Estimated
$371.6M
Actual
$353.7M4.8%
- OUSTOuster$2.7BReported
OUSTQ4 2023
Ouster
View full reportEPS
Estimated
-$0.83
Actual
-$0.9514.5%
Revenue
Estimated
$24.1M
Actual
$24.4M1.5%
- CNXCConcentrix$1.6BReported
CNXCQ1 2024
Concentrix
View full reportEPS
Estimated
$2.61
Actual
$0.7670.9%
Revenue
Estimated
$2.4B
Actual
$2.4B1.6%
- PRGSProgress Software$1.3BReported
PRGSQ1 2024
Progress Software
View full reportEPS
Estimated
$1.14
Actual
$0.5155.3%
Revenue
Estimated
$180.7M
Actual
$184.7M2.2%
- ANNXAnnexon$880MReported
ANNXQ4 2023
Annexon
View full reportEPS
Estimated
-$0.45
Actual
-$0.3620.0%
Revenue
Estimated
$0.00
Actual
$4.9M
- MOVMovado$786MReported
MOVQ4 2024
Movado
View full reportEPS
Estimated
$0.39
Actual
$0.5540.0%
Revenue
Estimated
$171.3M
Actual
$179.6M4.9%
- FRGEForge$619MReported
FRGEQ4 2023
Forge
View full reportEPS
Estimated
-$0.10
Actual
-$0.1546.3%
Revenue
Estimated
$20.0M
Actual
$19.1M4.5%
- GYREGyre Therapeutics$557MReported
GYREQ4 2023
Gyre Therapeutics
View full reportEPS
Estimated
-$0.60
Actual
-$1.31118.3%
Revenue
Estimated
$0.00
Actual
$27.1M
- PAYSPaysign$402MReported
PAYSQ4 2023
Paysign
View full reportEPS
Estimated
$0.06
Actual
$0.1077.0%
Revenue
Estimated
$7.5M
Actual
$13.7M82.5%
- CTASCintas$69.2BReported
CTASQ3 2024
Cintas
View full reportEPS
Estimated
$3.67
Actual
$3.844.6%
Revenue
Estimated
$2.4B
Actual
$2.4B1.3%
- CCLCarnival$34.6BReported
CCLQ1 2024
Carnival
View full reportEPS
Estimated
-$0.18
Actual
-$0.1421.4%
Revenue
Estimated
$5.5B
Actual
$5.4B2.2%
- JEFJefferies$10.7BReported
JEFQ1 2024
Jefferies
View full reportEPS
Estimated
$0.76
Actual
$0.8714.8%
Revenue
Estimated
$1.6B
Actual
$1.7B12.1%
- HSHPHimalaya Shipping Ltd$6.5BReported
HSHPQ4 2023
Himalaya Shipping Ltd
View full reportEPS
Estimated
$0.00
Actual
$0.04
Revenue
Estimated
$18.7M
Actual
$198.5M961.7%
- HSHPHimalaya Shipping Ltd$6.5BReported
HSHPQ4 2021
Himalaya Shipping Ltd
View full reportEPS
Estimated
—
Actual
-$0.06
Revenue
Estimated
—
Actual
—
- CELCCelcuity$6.4BReported
CELCQ4 2023
Celcuity
View full reportEPS
Estimated
-$0.71
Actual
-$0.6114.1%
Revenue
Estimated
$0.00
Actual
$229.6K
- UNFUniFirst$4.7BReported
UNFQ2 2024
UniFirst
View full reportEPS
Estimated
$1.42
Actual
$1.0923.3%
Revenue
Estimated
$583.4M
Actual
$590.7M1.3%
- PHIPLDT$4.0BReported
PHIQ4 2023
PLDT
View full reportEPS
Estimated
$0.55
Actual
-$0.10118.2%
Revenue
Estimated
$986.5M
Actual
$973.7M1.3%
- PHIPLDT$4.0BReported
PHIQ3 2023
PLDT
View full reportEPS
Estimated
$0.58
Actual
$0.7732.4%
Revenue
Estimated
$954.8M
Actual
$934.9M2.1%
- ERASErasca$3.8BReported
ERASQ4 2023
Erasca
View full reportEPS
Estimated
-$0.24
Actual
-$0.2016.7%
Revenue
Estimated
$0.00
Actual
$5.6M
- CCChemours$3.4BReported
CCQ4 2023
Chemours
View full reportEPS
Estimated
$0.30
Actual
$0.314.3%
Revenue
Estimated
$1.3B
Actual
$1.4B5.3%
- RUMRumble$3.2BReported
RUMQ4 2023
Rumble
View full reportEPS
Estimated
-$0.22
Actual
-$0.1436.4%
Revenue
Estimated
$28.1M
Actual
$20.4M27.5%
- CSANCosan$3.0BReported
CSANQ4 2023
Cosan
View full reportEPS
Estimated
$0.15
Actual
$0.63320.0%
Revenue
Estimated
$7.6B
Actual
$1.9B74.7%
- BHPBHP$166BReported
BHPQ2 2024
BHP
View full reportEPS
Estimated
$1.03
Actual
$0.1882.3%
Revenue
Estimated
$21.3B
Actual
$27.5B28.8%
- PLPlanet Labs$17.8BReported
PLQ4 2023
Planet Labs
View full reportEPS
Estimated
-$0.16
Actual
-$0.0663.1%
Revenue
Estimated
$53.6M
Actual
$58.9M9.7%
- SMTCSemtech$15.5BReported
SMTCQ4 2024
Semtech
View full reportEPS
Estimated
-$0.03
Actual
-$0.0683.9%
Revenue
Estimated
$198.2M
Actual
$192.9M2.6%
- HUTHut 8$14.0BReported
HUTQ4 2023
Hut 8
View full reportEPS
Estimated
-$0.26
Actual
-$0.0197.5%
Revenue
Estimated
$33.6M
Actual
$82.2M144.4%
- QBTSD-Wave$10.9BReported
QBTSQ4 2023
D-Wave
View full reportEPS
Estimated
-$0.10
Actual
-$0.102.4%
Revenue
Estimated
$4.8M
Actual
$2.9M39.3%
- WBAWalgreens$10.4BReported
WBAQ2 2024
Walgreens
View full reportEPS
Estimated
$0.82
Actual
$1.2047.0%
Revenue
Estimated
$35.2B
Actual
$37.1B5.2%
- CNTACentessa$6.2BReported
CNTAQ4 2023
Centessa
View full reportEPS
Estimated
-$0.48
Actual
-$0.3820.8%
Revenue
Estimated
$0.00
Actual
$6.9M
- MSMMSC$6.1BReported
MSMQ2 2024
MSC
View full reportEPS
Estimated
$1.17
Actual
$1.105.8%
Revenue
Estimated
$927.6M
Actual
$935.3M0.8%
- ATATAtour$3.9BReported
ATATQ4 2023
Atour
View full reportEPS
Estimated
$0.19
Actual
$0.2324.2%
Revenue
Estimated
$169.4M
Actual
$208.2M22.9%
- FULH.B. Fuller$3.5BReported
FULQ1 2024
H.B. Fuller
View full reportEPS
Estimated
$0.65
Actual
$0.673.8%
Revenue
Estimated
$829.2M
Actual
$810.4M2.3%
- IMNMImmunome$2.6BReported
IMNMQ4 2023
Immunome
View full reportEPS
Estimated
-$0.27
Actual
-$0.1545.1%
Revenue
Estimated
$2.0M
Actual
$3.8M88.9%
- KODKodiak Sciences$2.3BReported
KODQ4 2023
Kodiak Sciences
View full reportEPS
Estimated
-$0.86
Actual
-$1.1331.4%
Revenue
Estimated
$0.00
Actual
$0.00
- PLSEPulse Biosciences$1.7BReported
PLSEQ4 2023
Pulse Biosciences
View full reportEPS
Estimated
$0.00
Actual
-$0.15
Revenue
Estimated
$0.00
Actual
$0.00
- ATAIAtai$1.6BReported
ATAIQ4 2023
Atai
View full reportEPS
Estimated
-$0.17
Actual
-$0.1231.1%
Revenue
Estimated
$186.2K
Actual
$18.0K90.3%
- IMMXImmix Biopharma$481MReported
IMMXQ4 2023
Immix Biopharma
View full reportEPS
Estimated
-$0.23
Actual
-$0.244.3%
Revenue
Estimated
$0.00
Actual
$0.00
- OZBelpointe Prep$186MReported
OZQ2 2023
Belpointe Prep
View full reportEPS
Estimated
$0.00
Actual
-$1.16
Revenue
Estimated
$0.00
Actual
$778.0K
- OZBelpointe Prep$186MReported
OZQ4 2023
Belpointe Prep
View full reportEPS
Estimated
$0.00
Actual
-$1.17
Revenue
Estimated
$0.00
Actual
$511.0K
- KALAKala Bio$42.6MReported
KALAQ4 2023
Kala Bio
View full reportEPS
Estimated
-$3.61
Actual
-$3.1812.0%
Revenue
Estimated
$0.00
Actual
$70.0K
- PRPOPrecipio$41.7MReported
PRPOQ4 2023
Precipio
View full reportEPS
Estimated
-$0.95
Actual
$0.88192.3%
Revenue
Estimated
$4.3M
Actual
$4.3M0.9%
- ATNMActinium$36.1MReported
ATNMQ4 2023
Actinium
View full reportEPS
Estimated
-$0.53
Actual
-$0.3337.3%
Revenue
Estimated
$0.00
Actual
$81.0K
- TXMDTherapeuticsMD$24.4MReported
TXMDQ4 2023
TherapeuticsMD
View full reportEPS
Estimated
-$0.13
Actual
-$0.147.9%
Revenue
Estimated
$490.0K
Actual
$502.0K2.4%
- OGENOragenics$2.7MReported
OGENQ4 2023
Oragenics
View full reportEPS
Estimated
-$3.00
Actual
-$5.4882.7%
Revenue
Estimated
$0.00
Actual
-$37.7K
- ENSVEnservco$29100Reported
ENSVQ4 2023
Enservco
View full reportEPS
Estimated
-$0.05
Actual
-$0.0743.6%
Revenue
Estimated
$6.5M
Actual
$6.5M0.2%
- MONDMondee$8700Reported
MONDQ4 2023
Mondee
View full reportEPS
Estimated
-$0.09
Actual
-$0.22144.4%
Revenue
Estimated
$55.0M
Actual
$61.1M11.0%
- PVHPVH$4.5BReported
PVHQ4 2024
PVH
View full reportEPS
Estimated
$3.38
Actual
$3.7210.2%
Revenue
Estimated
$2.3B
Actual
$2.5B10.2%
- BRK-BBerkshire Hathaway$1.03TReported
BRK-BQ1 2024
Berkshire Hathaway
View full reportEPS
Estimated
—
Actual
—
Revenue
Estimated
—
Actual
$89.9B
- PWRQuanta Services$110BReported
PWRQ1 2024
Quanta Services
View full reportEPS
Estimated
$1.30
Actual
$0.7939.1%
Revenue
Estimated
$5.0B
Actual
$5.0B0.1%
- AUAngloGold Ashanti$48.6BReported
AUQ1 2024
AngloGold Ashanti
View full reportEPS
Estimated
—
Actual
$0.16
Revenue
Estimated
—
Actual
$1.3B
- BMWKYBMW$45.9BReported
BMWKYQ1 2024
BMW
View full reportEPS
Estimated
$4.27
Actual
$4.423.5%
Revenue
Estimated
$39.8B
Actual
$36.6B8.0%
- CMSCMS Energy$22.6BReported
CMSQ1 2024
CMS Energy
View full reportEPS
Estimated
$0.95
Actual
$0.960.9%
Revenue
Estimated
$2.3B
Actual
$2.2B7.1%
- NINisource$22.4BReported
NIQ1 2024
Nisource
View full reportEPS
Estimated
$0.84
Actual
$0.777.9%
Revenue
Estimated
$2.4B
Actual
$1.7B29.0%
- ULSUL Solutions Inc$20.1BReported
ULSQ1 2024
UL Solutions Inc
View full reportEPS
Estimated
—
Actual
$0.28
Revenue
Estimated
—
Actual
$670.0M
- THCTenet Healthcare$14.9BReported
THCQ1 2024
Tenet Healthcare
View full reportEPS
Estimated
$1.50
Actual
$21.601336.3%
Revenue
Estimated
$5.2B
Actual
$5.4B3.1%
- OMVKYOmv AG$14.9BReported
OMVKYQ1 2024
Omv AG
View full reportEPS
Estimated
$1.86
Actual
$1.4919.9%
Revenue
Estimated
$9.4B
Actual
$8.2B13.5%